BBNX Operating Margin
-69.75%TTM
Period ending:
BBNX FY Operating Margin%
4336.30%-41190.14%
2022-12-312025-12-31
Source: Financial Modeling Prep (FMP). Annual fiscal periods. Dates are period ends; a fiscal year may differ from a calendar year.
BBNX operating margin history
Operating income as a percentage of revenue. The available annual fiscal periods series contains 4 observations from Dec 31, 2022 to Dec 31, 2025.
| Period ending | Operating Margin |
|---|---|
| -71.5015% | |
| -69.4844% | |
| -298.8745% | |
| -36,784.3575% |
Compare operating margin
Other companies in Health Care. Each page shows its own reporting periods and currency.
- Guardant Health Inc (GH) operating margin
- Bridgebio Pharma Inc (BBIO) operating margin
- Brightspring Health Services Inc (BTSG) operating margin
- Madrigal Pharmaceuticals Inc (MDGL) operating margin
- Ensign Group Inc (ENSG) operating margin
- Glaukos Corp (GKOS) operating margin
- Krystal Biotech Inc (KRYS) operating margin
- Twist Bioscience Corp (TWST) operating margin
Compare all covered stocks by operating margin →
All BBNX financial metrics · BBNX stock overview · How to interpret financial metrics
